5.51
Precedente Chiudi:
$5.55
Aprire:
$5.65
Volume 24 ore:
300.90K
Relative Volume:
1.30
Capitalizzazione di mercato:
$199.97M
Reddito:
$16.10M
Utile/perdita netta:
$-42.57M
Rapporto P/E:
-3.907
EPS:
-1.4103
Flusso di cassa netto:
$-38.53M
1 W Prestazione:
+3.77%
1M Prestazione:
-16.52%
6M Prestazione:
+36.39%
1 anno Prestazione:
-21.29%
Profound Medical Corp Stock (PROF) Company Profile
Nome
Profound Medical Corp
Settore
Industria
Telefono
647-476-1350
Indirizzo
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
PROF
Profound Medical Corp
|
5.51 | 199.97M | 16.10M | -42.57M | -38.53M | -1.4103 |
|
ABT
Abbott Laboratories
|
108.03 | 187.72B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 128.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 102.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 47.52B | 6.07B | 1.06B | 1.34B | 1.8063 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-23 | Iniziato | Lake Street | Buy |
| 2024-07-16 | Aggiornamento | Stifel | Hold → Buy |
| 2023-11-28 | Iniziato | Stifel | Hold |
| 2023-08-04 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | Downgrade | Jefferies | Buy → Hold |
| 2020-09-15 | Iniziato | Jefferies | Buy |
Mostra tutto
Profound Medical Corp Borsa (PROF) Ultime notizie
Profound Medical reports CAPTAIN trial meets primary safety endpoint - Yahoo Finance
Profound Medical's (PROF) TULSA Procedure Shows Superior Safety Outcomes - GuruFocus
Profound Medical Corp. Reports Results of CAPTAIN Trial Comparing MRI-Guided TULSA Procedure to Robotic Radical Prostatectomy - marketscreener.com
CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence - Bitget
Profound Medical Trial Shows TULSA Improves Prostate Cancer Outcomes - TipRanks
Profound Medical (PROF) trial: TULSA tops robotic surgery on key safety outcomes - Stock Titan
Prostate trial: MRI-guided TULSA helps more men keep sex and bladder control - Stock Titan
Aug Outlook: What hedge funds are buying Profound Medical Corp2026 Analyst Calls & Risk Controlled Swing Alerts - baoquankhu1.vn
(PRN) Comprehensive Trading Strategy Report (PRN:CA) - Stock Traders Daily
Profound Medical Announces Board Resignation and New Appointment - TipRanks
Medical Co.'s TULSA-PRO Installed Base Growth & CAPTAIN Trial Data Could Accelerate Adoption in 2026 - streetwisereports.com
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24 - Investing News Network
Profound Medical to Host Investor Call March 13 on First CAPTAIN Trial Outcomes Presented at EAU 2026 - TradingView
Profound Medical (PROF) Awaits Key Clinical Data Presentation - GuruFocus
Profound Medical to Present First CAPTAIN Trial Results and Steps Up Investor Outreach - TipRanks
(PRN) Technical Pivots with Risk Controls (PRN:CA) - Stock Traders Daily
Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript - Insider Monkey
Profound Medical (TSX:PRN) Narrowing EPS Loss In Q3 2025 Tests Growth Optimism Narrative - simplywall.st
History Review: Can Profound Medical Corp beat the S P 500Market Volume Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Street Watch: Is OVBC forming a bullish divergenceEarnings Performance Report & Verified Swing Trading Watchlist - baoquankhu1.vn
Profound Medical (TSE:PRN) Trading Down 26%Time to Sell? - MarketBeat
Profound Medical reports net loss of USD 8.2M in Q4 2025 - Medical Buyer
Profound Medical (NASDAQ:PROF) Issues Earnings Results - MarketBeat
Profound Medical Corp (PROF) Q4 2025 Earnings Call Highlights: R - GuruFocus
Profound Medical Posts Record Q4 Revenue as TULSA-PRO Adoption and Global Expansion Accelerate - The Globe and Mail
Profound Medical Q4 Earnings Call Highlights - Yahoo Finance
Aug Sentiment: Can Profound Medical Corp beat the S P 500July 2025 Weekly Recap & Stepwise Swing Trade Plans - baoquankhu1.vn
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results - Investing News Network
Earnings call transcript: Profound Medical Q4 2025 EPS surprises, stock rises - Investing.com South Africa
Profound Medical (PROF) Reports Q4 Revenue Below Expectations - GuruFocus
Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Profound 10-K: Revenue $16.1M, EPS loss $1.41 - TradingView
Profound Medical Q4 Earnings Assessment - Benzinga
Profound Medical Corp. Q4 Profit Climbs - Nasdaq
Profound Medical Brief: Reports Q4 Revenue of US$6.0 Mln, Up From US$4.2 Mln a Year Earlier - marketscreener.com
Profound Medical Brief: Reports a Fourth-Quarter Loss of US$8.2 Mln, or US$0.27 per Share, Compared To a Loss of US$4.9 Mln, or US$0.20 in the Year-Prior Quarter - marketscreener.com
Profound Medical $PROF Shares Purchased by First Eagle Investment Management LLC - MarketBeat
Profound Medical's Earnings: A Preview - Benzinga
Profound Medical Corp (PROF) Q4 2025 Earnings Report Preview: Wh - GuruFocus
(PRN) On The My Stocks Page (PRN:CA) - Stock Traders Daily
Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline - Finviz
Profound Medical (PROF) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Risk Hedge: What is the Moat Score of NYXHEntry Point & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Tech Rally: What hedge funds are buying Profound Medical CorpPortfolio Growth Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Energy Moves: Can Affimed NV outperform under higher oil pricesInsider Selling & Weekly Consistent Profit Watchlists - baoquankhu1.vn
(PRN) Risk-Controlled Trading Report (PRN:CA) - Stock Traders Daily
Certain stock options of Profound Medical Corp. are subject to a Lock-Up Agreement Ending on 22-FEB-2026. - marketscreener.com
Is Profound Medical Corp. trading at a discountPortfolio Profit Report & Daily Stock Momentum Reports - mfd.ru
Profound Medical (TSE:PRN) Stock Price Up 2.6%What's Next? - MarketBeat
Profound Medical launches up to $40 million equity financing to support growth - MSN
(PRN) Strategic Market Analysis (PRN:CA) - Stock Traders Daily
Profound Medical Corp Azioni (PROF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):